OESTROGENERATION CIC

Company limited by guarantee

Company Registration Number:
14025042 (England and Wales)

Unaudited statutory accounts for the year ended 30 April 2024

Period of accounts

Start date: 1 May 2023

End date: 30 April 2024

OESTROGENERATION CIC

Contents of the Financial Statements

for the Period Ended 30 April 2024

Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

OESTROGENERATION CIC

Balance sheet

As at 30 April 2024

Notes 2024 13 months to 30 April 2023


£

£
Current assets
Debtors: 3 2,830 65
Cash at bank and in hand: 6,793 14,554
Total current assets: 9,623 14,619
Creditors: amounts falling due within one year: 4 ( 2,314 ) ( 10,554 )
Net current assets (liabilities): 7,309 4,065
Total assets less current liabilities: 7,309 4,065
Total net assets (liabilities): 7,309 4,065
Members' funds
Profit and loss account: 7,309 4,065
Total members' funds: 7,309 4,065

The notes form part of these financial statements

OESTROGENERATION CIC

Balance sheet statements

For the year ending 30 April 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 27 January 2025
and signed on behalf of the board by:

Name: Harietta Lindsey
Status: Director

The notes form part of these financial statements

OESTROGENERATION CIC

Notes to the Financial Statements

for the Period Ended 30 April 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

OESTROGENERATION CIC

Notes to the Financial Statements

for the Period Ended 30 April 2024

  • 2. Employees

    2024 13 months to 30 April 2023
    Average number of employees during the period 2 2

OESTROGENERATION CIC

Notes to the Financial Statements

for the Period Ended 30 April 2024

3. Debtors

2024 13 months to 30 April 2023
£ £
Other debtors 2,830 65
Total 2,830 65

OESTROGENERATION CIC

Notes to the Financial Statements

for the Period Ended 30 April 2024

4. Creditors: amounts falling due within one year note

2024 13 months to 30 April 2023
£ £
Taxation and social security 1,714 954
Accruals and deferred income 600 9,600
Total 2,314 10,554

COMMUNITY INTEREST ANNUAL REPORT

OESTROGENERATION CIC

Company Number: 14025042 (England and Wales)

Year Ending: 30 April 2024

Company activities and impact

In the space provided below, please insert a general account of the company’s activities in the financial year to which the report relates, including a fair and accurate description of how they have benefited the community, or section of the community, which the company is intended to serve. Oestrogeneration is an online magazine & events company for and by trans women. During this financial year, Oestrogeneration has a been able to serve the community by hosting weekly fundraisers from November 2023 that have given directly to community members in need of life-saving healthcare. We released the first print issue of our magazine that hired a team of trans women to write & design the magazine, creating work that disrupts the transphobic media landscape in the UK. We have hosted numerous events for our community from night club events to cinema screenings, creating a safe space to cultivate connection & support amongst trans women and our allies.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

The total amount paid or receivable by directors in respect of qualifying services was £13,909. There were no other transactions or arrangements in connection with the remuneration of directors, or compensation for director’s loss of office, which require to be disclosed.

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
26 January 2025

And signed on behalf of the board by:
Name: Harietta Lindsey
Status: Director